Polu joins Frazier Healthcare
Frazier Healthcare Partners said Feb. 15 that Dr. Krishna Polu has joined the Life Sciences operating professional team as an entrepreneur-in-residence with Hawkeye Therapeutics. Dr. Polu previously served as chief medical officer at Raptor Pharmaceuticals until its acquisition by Horizon Pharmaceuticals in 2016.



